144 related articles for article (PubMed ID: 23388163)
1. An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Warnke C; Pawlita M; Dehmel T; Posevitz-Fejfar A; Hartung HP; Wiendl H; Kieseier BC; Adams O
Mult Scler; 2013 Aug; 19(9):1137-44. PubMed ID: 23388163
[TBL] [Abstract][Full Text] [Related]
2. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
3. Anti-JC virus antibodies: implications for PML risk stratification.
Gorelik L; Lerner M; Bixler S; Crossman M; Schlain B; Simon K; Pace A; Cheung A; Chen LL; Berman M; Zein F; Wilson E; Yednock T; Sandrock A; Goelz SE; Subramanyam M
Ann Neurol; 2010 Sep; 68(3):295-303. PubMed ID: 20737510
[TBL] [Abstract][Full Text] [Related]
4. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Trampe AK; Hemmelmann C; Stroet A; Haghikia A; Hellwig K; Wiendl H; Goelz S; Ziegler A; Gold R; Chan A
Neurology; 2012 May; 78(22):1736-42. PubMed ID: 22592369
[TBL] [Abstract][Full Text] [Related]
5. The effect of plasma exchange on serum anti-JC virus antibodies.
Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
[TBL] [Abstract][Full Text] [Related]
6. Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma.
Plavina T; Berman M; Njenga M; Crossman M; Lerner M; Gorelik L; Simon K; Schlain B; Subramanyam M
J Clin Virol; 2012 Jan; 53(1):65-71. PubMed ID: 22104399
[TBL] [Abstract][Full Text] [Related]
7. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy.
Aoki N; Mori M; Kato K; Sakamoto Y; Noda K; Tajima M; Shimada H
Neurosci Lett; 1996 Feb; 205(2):111-4. PubMed ID: 8907329
[TBL] [Abstract][Full Text] [Related]
8. Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.
Bozic C; Subramanyam M; Richman S; Plavina T; Zhang A; Ticho B
Eur J Neurol; 2014 Feb; 21(2):299-304. PubMed ID: 24894998
[TBL] [Abstract][Full Text] [Related]
9. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
[TBL] [Abstract][Full Text] [Related]
10. Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies.
Auer M; Borena W; Holm-von Laer D; Deisenhammer F
J Med Virol; 2017 Jan; 89(1):3-9. PubMed ID: 27253624
[TBL] [Abstract][Full Text] [Related]
11. Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Basnyat P; Hagman S; Kolasa M; Koivisto K; Verkkoniemi-Ahola A; Airas L; Elovaara I
Mult Scler Relat Disord; 2015 Jul; 4(4):334-8. PubMed ID: 26195052
[TBL] [Abstract][Full Text] [Related]
12. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.
Viscidi RP; Rollison DE; Viscidi E; Clayman B; Rubalcaba E; Daniel R; Major EO; Shah KV
Clin Diagn Lab Immunol; 2003 Mar; 10(2):278-85. PubMed ID: 12626455
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection and differentiation of human polyomaviruses JC and BK by a rapid and sensitive PCR-ELAHA assay and a survey of the JCV subtypes within an Australian population.
Whiley DM; Arden KE; Mackay IM; Syrmis MW; Sloots TP
J Med Virol; 2004 Mar; 72(3):467-72. PubMed ID: 14748071
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Vennegoor A; van Rossum JA; Polman CH; Wattjes MP; Killestein J
Mult Scler; 2015 Oct; 21(12):1600-3. PubMed ID: 25662344
[TBL] [Abstract][Full Text] [Related]
15. BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis.
Behzad-Behbahani A; Klapper PE; Vallely PJ; Cleator GM; Bonington A
Infection; 2003 Dec; 31(6):374-8. PubMed ID: 14735377
[TBL] [Abstract][Full Text] [Related]
16. Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Olsson T; Achiron A; Alfredsson L; Berger T; Brassat D; Chan A; Comi G; Eraksoy M; Hegen H; Hillert J; Jensen PE; Moiola L; Myhr KM; Oturai A; Schippling S; Siva A; Sorensen PS; Trampe AK; Weber T; Potts J; Plavina T; Paes D; Subramanyam M; Wiendl H; Dib H; Uren D; Hemmer B; Buck D
Mult Scler; 2013 Oct; 19(11):1533-8. PubMed ID: 23459571
[TBL] [Abstract][Full Text] [Related]
17. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.
Dominguez-Mozo MI; Rus M; Santiago JL; Izquierdo G; Casanova I; Galan V; Garcia-Martinez MA; Arias-Leal AM; García-Montojo M; Pérez-Pérez S; Arroyo R; Alvarez-Lafuente R
Eur J Clin Invest; 2017 Feb; 47(2):158-166. PubMed ID: 28036121
[TBL] [Abstract][Full Text] [Related]
18. Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Warnke C; Ramanujam R; Plavina T; Bergström T; Goelz S; Subramanyam M; Kockum I; Rahbar A; Kieseier BC; Holmén C; Olsson T; Hillert J; Fogdell-Hahn A
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1199-205. PubMed ID: 23463870
[TBL] [Abstract][Full Text] [Related]
19. JCV epidemiology in MS (JEMS)--epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients--Portuguese data.
da Silva AM; Santos ME;
J Neurol Sci; 2014 Feb; 337(1-2):119-22. PubMed ID: 24369270
[TBL] [Abstract][Full Text] [Related]
20. Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
Kardas P; Leboeuf C; Hirsch HH
J Clin Virol; 2015 Oct; 71():28-33. PubMed ID: 26370311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
